Oxymetazoline, an alpha(2) agonist, was active in lowering intraocular
pressure in normal and sympathetically denervated rabbit eyes. Ocular
hypotension was accompanied by decreased aqueous humor inflow. Topica
l pretreatment with rauwolscine, an alpha(2) antagonist, reduced the o
xymetazoline-induced hypotensive effect more in contralateral than in
ipsilateral eyes indicating the possible involvement of central alpha(
2) adrenoceptors. Efaroxan, a relatively selective: imidazoline antago
nist, and diclofenac, a cyclooxygenase inhibitor, failed to inhibit th
e oxymetazoline-induced ocular hypotensive response. Oxymetazoline ind
uced mydriasis in treated eyes at all doses. In in vitro studies, oxym
etazoline inhibited isoproterenol-stimulated cAMP production in rabbit
iris-ciliary bodies and cultured rabbit nonpigmented ciliary epitheli
al cells. The inhibition of cAMP accumulation induced by oxymetazoline
was antagonized by rauwolscine or by BRL-44408, a relatively selectiv
e alpha(2A)-adrenoceptor antagonist. These data indicate that oxymetaz
oline lowered intraocular pressure by activating alpha(2A) receptors (
ciliary epithelium) and that the ocular hypotensive effect was not tot
ally dependent on intact sympathetic nerves. Results suggest that mech
anisms involving centrally mediated effects of oxymetazoline are proba
ble and this possibility is currently under investigation.